UK Penny Stocks To Consider In July 2026

The UK market has faced challenges recently, with the FTSE 100 and FTSE 250 indices closing lower due to weak trade data from China, highlighting concerns about global economic recovery. Despite these headwinds, investors can still find opportunities by exploring penny stocks—smaller or newer companies that may offer unique value propositions. While the term "penny stocks" might seem outdated, these investments continue to be relevant for those seeking potential growth and stability in under-the-radar firms with strong financial foundations.

Let's dive into some prime choices out of the screener.

Big Technologies (AIM:BIG)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Big Technologies PLC, operating under the Buddi brand, develops and provides remote monitoring technologies and services primarily for the criminal justice sectors, with a market cap of £284.63 million.

Operations: The company generates revenue of £49.73 million from its electronic tracking devices, products, and services segment.

Market Cap: £284.63M

Big Technologies PLC, with a market cap of £284.63 million, is navigating through a transitional phase marked by leadership changes. The appointment of Charles Lewinton as Acting CEO follows the retirement of Ian Johnson, who had strengthened the company's management and laid groundwork for growth. Despite being unprofitable with negative return on equity (-25.4%), Big Technologies has no debt and strong short-term assets (£117.4M) exceeding liabilities (£49.9M). Revenue from its electronic tracking segment stands at £49.73 million, while shares trade below estimated fair value, suggesting potential investor interest despite current profitability challenges.

• Dive into the specifics of Big Technologies here with our thorough balance sheet health report.
• Gain insights into Big Technologies' future direction by reviewing our growth report.

Intercede Group (AIM:IGP)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Intercede Group plc is a cybersecurity company that develops and supplies identity and credential management software for digital trust, operating primarily in the United Kingdom, Europe, the United States, and internationally, with a market cap of £67.68 million.

Operations: The company's revenue is primarily derived from its Software & Programming segment, which generated £17.16 million.

Market Cap: £67.68M

Intercede Group plc, with a market cap of £67.68 million, is navigating volatility in its share price while maintaining a debt-free balance sheet. The company reported sales of £17.16 million for the year ending March 2026, though net income declined to £3.38 million from the previous year. Despite negative earnings growth recently, Intercede's earnings have grown significantly over five years and are forecasted to grow annually by 17.48%. Recent strategic partnerships with Swissbit AG and OneSpan aim to enhance its FIDO2 authentication offerings and broaden market reach through high-quality channel partners, potentially bolstering future revenue streams.

• Jump into the full analysis health report here for a deeper understanding of Intercede Group.
• Assess Intercede Group's future earnings estimates with our detailed growth reports.

Venture Life Group (AIM:VLG)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Venture Life Group plc develops and commercializes healthcare products in the United Kingdom, with a market cap of £84.67 million.

Operations: The company's revenue segment includes £35.17 million from Venture Life Brands.

Market Cap: £84.67M

Venture Life Group plc, with a market cap of £84.67 million, is currently unprofitable but has strong financial health with short-term assets of £50.5 million exceeding both short-term (£10.7M) and long-term liabilities (£7M). The company trades at 76% below its estimated fair value, indicating potential for valuation growth. Despite increasing losses over the past five years, earnings are forecasted to grow significantly at 101.6% annually. Debt levels have improved markedly, with cash exceeding total debt and operating cash flow covering debt by 161.3%. However, interest payments are not well covered by EBIT (1.3x coverage).

• Get an in-depth perspective on Venture Life Group's performance by reading our balance sheet health report here.
• Explore Venture Life Group's analyst forecasts in our growth report.

Taking Advantage

• Unlock our comprehensive list of 279 UK Penny Stocks by clicking here.
• Curious About Other Options? The latest GPUs need a type of rare earth metal called Terbium and there are only 29 companies in the world exploring or producing it. Find the list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com